Inventor · disambiguated record
John Wang
Also filed as: WANG JOHN · WANG JOHN YUAN
16 granted patents·15 pending applications·71 citations·filing 2003–2025
92Inventor score
Top patents by PatentIndex Score
31 records- 0190US9434697B2Pyrimidine FGFR4 inhibitorsEISAI R&D MAN CO LTD·Filed 2016·Granted Sep 6, 2016·8 cites·30 claims
- 0289US9730931B2Pyrimidine FGFR4 inhibitorsEISAI R&D MAN CO LTD·Filed 2016·Granted Aug 15, 2017·7 cites·11 claims
- 0385US9796683B2Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2016·Granted Oct 24, 2017·6 cites·32 claims
- 0485US8937056B2Multikinase inhibitors for use in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2013·Granted Jan 20, 2015·3 cites·14 claims
- 0584US9481669B2Pladienolide pyridine compounds and methods of useEISAI R&D MAN CO LTD·Filed 2015·Granted Nov 1, 2016·7 cites·46 claims
- 0684US8329742B2Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2010·Granted Dec 11, 2012·9 cites·32 claims
- 0782US7799827B2Macrocyclic compounds useful as pharmaceuticalsEISAI CO LTD·Filed 2003·Granted Sep 21, 2010·16 cites·30 claims
- 0877US7915306B2Macrocyclic compounds useful as pharmaceuticalsEISAI CO LTD·Filed 2003·Granted Mar 29, 2011·13 cites·92 claims
- 0976US10912774B2Pyrimidine FGFR4 inhibitorsEISAI R&D MAN CO LTD·Filed 2019·Granted Feb 9, 2021·0 cites·20 claims
- 1074US2024368140A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 1172US11926619B2Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 12, 2024·1 cites·18 claims
- 1269US11160783B2Multikinase inhibitors for use in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2018·Granted Nov 2, 2021·0 cites·18 claims
- 1369US2025074942A1Compositions and methods for covalent peptide-based modulators of hla-eCALICO LIFE SCIENCES LLC·Filed 2024·Application pending·0 cites
- 1467US8609640B2Multikinase inhibitors for use in the treatment of cancerAGOULNIK SERGEI·Filed 2008·Granted Dec 17, 2013·1 cites·15 claims
- 1567US2025333400A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2025·Application pending·0 cites
- 1662US2025313574A1Sialic acid derivatives and methods of using sameEISAI R&D MAN CO LTD·Filed 2023·Application pending·0 cites
- 1761US2025092392A1Antisense oligonucleotides and their use for treatment of neurodegenerative disordersEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 1860US11498916B2Crystalline FGFR4 inhibitor compound and uses thereofEISAI R&D MAN CO LTD·Filed 2019·Granted Nov 15, 2022·0 cites·18 claims
- 1959US10537571B2Pyrimidine FGFR4 inhibitorsEISAI R&D MAN CO LTD·Filed 2017·Granted Jan 21, 2020·0 cites·12 claims
- 2059US2015182496A1Multikinase inhibitors for use in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2015·Application pending·0 cites
- 2157US2020361915A1Solid state form of pladienolide pyridine compounds and methods of useEISAI R&D MAN CO LTD·Filed 2020·Application pending·0 cites
- 2256US10745387B2Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereofEISAI R&D MAN CO LTD·Filed 2016·Granted Aug 18, 2020·0 cites·26 claims
- 2356US2009170925A1Methods for prognosing the ability of a zearalenone analog compound to treat cancerEISAI R&D MAN CO LTD·Filed 2008·Application pending·0 cites
- 2455US2024060068A1Poly-morpholino oligonucleotide gapmersFANG FRANCIS G·Filed 2021·Application pending·0 cites
- 2552US2016291027A1Methods for prognosing the ability of a zearalenone analog compound to treat cancerEISAI R&D MAN CO LTD·Filed 2016·Application pending·0 cites
- 2652US2009048333A1Zearalenone Macrolide Derivatives and Uses of the SameEISAI CO LTD·Filed 2008·Application pending·0 cites
- 2751US2013196987A1Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2012·Application pending·0 cites
- 2850US2018141913A1Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 2950US2020255415A1Tetrasubstituted alkene compounds and their use for the treatment of breast cancerEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 3049US10851065B2Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Granted Dec 1, 2020·0 cites·20 claims
- 3138US2019337921A1Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →